| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 03/03/2005 | WO2004091530A3 Homogeneous, thermoreversible gel film containing kappa-2 carrageenan and soft capsules made therefrom |
| 03/03/2005 | WO2004091521A3 Methods and compositions for administration of trpv1 agonists |
| 03/03/2005 | WO2004091476A3 Method of screening remedy for heart disease and medicinal composition for treating heart disease |
| 03/03/2005 | WO2004089280A3 Reversible pegylated drugs |
| 03/03/2005 | WO2004087100A3 Cladribine formulations for improved oral and transmucosal delivery |
| 03/03/2005 | WO2004087054A3 Methods for modulating gastric secretion using prokineticin receptor antagonists. |
| 03/03/2005 | WO2004084801A3 Treatments for leishmaniasis |
| 03/03/2005 | WO2004082606A8 Fused pyrrole compounds |
| 03/03/2005 | WO2004080405A3 Igf-binding protein-derived peptide or small molecule |
| 03/03/2005 | WO2004076410A3 Polymorphs of pyrrole substituted 2-indolinone protein kinase inhibitors |
| 03/03/2005 | WO2004075835A3 Methods for the treatment of renal cell carcinoma |
| 03/03/2005 | WO2004073640A3 Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy |
| 03/03/2005 | WO2004073623A3 Treatment of conditions associated with decreased nitric oxide bioavailability, including elevated arginase conditions |
| 03/03/2005 | WO2004071411A3 Methods and compositions in treating pain and painful disorders using 16386, 15402, 21165, 1423, 636, 12303, 21425, 27410, 38554, 38555, 55063, 57145, 59914, 94921, 16852, 33260, 58573, 30911, 85913, 14303, 16816, 17827 or 32620 |
| 03/03/2005 | WO2004071395A3 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor ox1r (ox1r) |
| 03/03/2005 | WO2004069182A3 Active immunization to generate antibodies to soluble a-beta |
| 03/03/2005 | WO2004062627A3 In vivo screening models for treatment of alzheimer's disease and other neurodegenerative disorders |
| 03/03/2005 | WO2004054513A3 Methods and compositions for treating and preventing ear infections |
| 03/03/2005 | WO2003099219A3 Bryostatins, bryopyrans and polyketides: compositions and methods |
| 03/03/2005 | US20050049660 Systems and methods for treating hemorrhoids |
| 03/03/2005 | US20050049508 Treatment of age-related macular degeneration |
| 03/03/2005 | US20050049370 Anti-virus hydrophilic polymeric material |
| 03/03/2005 | US20050049278 Anticarcinogenic agents; synthesis |
| 03/03/2005 | US20050049244 osteoporosis; antiarthritic agents; antidiabetic agents; antiinflammatory agents; Alzheimer's disease; shock; central nervous stsrem disorders; anticancer agents; multiple sclerosis |
| 03/03/2005 | US20050049236 Sulfonamide-substituted chalcone derivatives and their use to treat diseases |
| 03/03/2005 | US20050049233 Transdermal administering of testosterone |
| 03/03/2005 | US20050049214 Inhibition of E3-ubiquitin ligase HAKAI for treatment of proliferative disorders |
| 03/03/2005 | US20050049179 For analyzing and prescribing changes to daily insulin-dosing schedule of diabetic patients using insulin pumps, multiple-dose injection, or inhaled insulin; divides day into selected time intervals in which adjustable schedules are provided for Basal Insulin dosage rates, Carbohydrate-to-insulin ratios |
| 03/03/2005 | US20050049155 A cleaning device comprising a power head having a moveable squeegee element configured to a working surface; and, a second region with bristles configured to treat concurrently the working surface but able to move independently; efficiency; teeth, floors, cars, wafers and/or appliances |
| 03/03/2005 | US20050048867 Building element for constructing a modular substructure |
| 03/03/2005 | US20050048622 Neuregulin fusion comprising epidermal growth factor domain for use in treatment and prevention of nervous system and neurodegenerative disorders |
| 03/03/2005 | US20050048593 Methods for the identification of inhibitors of acetolactate synthase as antibiotics |
| 03/03/2005 | US20050048585 Identifying modulators of nuclear factor of activated t-cells (NF-AT) actvity for use in treatment of cell proliferative and autoimmune diseases; immunosuppressants |
| 03/03/2005 | US20050048574 Biomarkers for diagnosing rheumatoid arthritis |
| 03/03/2005 | US20050048546 Coded metal nanoparticle comprising an oligonucleotide for use as diagnostic tool in identifying restriction fragment length polymorphisms and microorganismal genomic sequences |
| 03/03/2005 | US20050048131 Anti-virus hydrophilic polymeric material |
| 03/03/2005 | US20050048127 Small spherical particles of low molecular weight organic molecules and methods of preparation and use thereof |
| 03/03/2005 | US20050048114 Antibiotic product, use and formulation thereof |
| 03/03/2005 | US20050048089 Topical delivery system containing colloidal crystalline arrays |
| 03/03/2005 | US20050048074 Transgenic plant comprising nucleotide sequences coding hemagglutinin-neuraminidase (HN) proteins of newcastle disease viruses; for use in producing immunoprotective particles; vaccine preparation |
| 03/03/2005 | US20050048072 Topical administering mixtuure of immune response moderator and another drug |
| 03/03/2005 | US20050048042 Compositions and methods for the treatment of schizophrenia and addictive disorders |
| 03/03/2005 | US20050045476 Systems and methods for blood glucose sensing |
| 03/03/2005 | CA2848954A1 Compositions containing sertoli cells and myoid cells and use thereof in cellular transplants |
| 03/03/2005 | CA2551075A1 Immunostimulatory combinations and treatments |
| 03/03/2005 | CA2536946A1 Estrogen receptor modulators and uses thereof |
| 03/03/2005 | CA2536504A1 Heparin binding proteins: sensors for heparin detection |
| 03/03/2005 | CA2536349A1 6-cycloamino-2-quinolinone derivatives as androgen receptor modulator compounds |
| 03/03/2005 | CA2536340A1 Compositions of a cyclooxygenase-2 selective inhibitor and a serotonin modulating agent for the treatment of neoplasia |
| 03/03/2005 | CA2536173A1 Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use |
| 03/03/2005 | CA2536086A1 Inhibition of dr3 in the treatment of allergic lung inflammation |
| 03/03/2005 | CA2535945A1 Topical delivery system containing colloidal crystalline arrays |
| 03/03/2005 | CA2535944A1 Blockade of mtor to prevent a hormonal adaptive response |
| 03/03/2005 | CA2535803A1 Compositions for delivering 5-ht agonists across the oral mucosa and methods of use thereof |
| 03/03/2005 | CA2535353A1 Enzymatic processes for the production of 4-substituted 3-hydroxybutyric acid derivatives and vicinal cyano, hydroxy substituted carboxylic acid esters |
| 03/03/2005 | CA2535337A1 Macrocyclic beta-secretase inhibitors for the treatment of alzheimer's disease |
| 03/03/2005 | CA2535120A1 Hydroxylamine substituted imidazo-containing compounds |
| 03/03/2005 | CA2535117A1 Oxime substituted imidazo-containing compounds |
| 03/03/2005 | CA2533895A1 Methods of reducing risk of infection from pathogens |
| 03/03/2005 | CA2533889A1 Mitotic kinesin inhibitors |
| 03/03/2005 | CA2531022A1 Compositions containing sertoli cells and myoid cells and use thereof in cellular transplants |
| 03/03/2005 | CA2526853A1 Structure based and combinatorially selected oligonucleoside phosphorothioate and phosphorodithioate aptamer targeting ap-1 transcription factors |
| 03/03/2005 | CA2525619A1 Methods and compositions for rna interference |
| 03/03/2005 | CA2519337A1 Anti-cancer virus desensitization method |
| 03/02/2005 | EP1510214A2 8a-azalides as veterinary antimicrobial agents |
| 03/02/2005 | EP1180102B9 Mutual prodrugs of amlodipine and atorvastatin |
| 03/02/2005 | CN1589330A Stem cells of the islets of langerhans and their use in treating diabetes |
| 03/02/2005 | CN1589261A Piperidine derivatives and their use as modulators of chemokine receptor activity (especially CCR5) |
| 03/02/2005 | CN1589260A Heterocyclic compounds and methods of use thereof |
| 03/02/2005 | CN1589151A Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof |
| 03/02/2005 | CN1589147A Use of N-(indolecarbonyl-)piperazine derivatives |
| 03/02/2005 | CN1589140A Combination of selected opioids with muscarine antagonists for treating urinary incontinence |
| 03/02/2005 | CN1191266C Compositions for treating inflammatory response |
| 03/02/2005 | CN1191263C 3-deoxy-desmycosin derivatives and process for their preparation |
| 03/02/2005 | CN1191061C Medical compositions |
| 03/02/2005 | CN1191052C Dual component dentinal desensitizing dentifrice |
| 03/02/2005 | CN1191050C Application of two kinds of cationic dye mixture in direct dyeing of keratin fiber |
| 03/01/2005 | US6861446 C7 heterosubstituted acetate taxane compositions |
| 03/01/2005 | US6861043 Cascade polymer complexes, process for their production and pharmaceutical agents containing said complexes |
| 03/01/2005 | US6860668 Method and apparatus for improved stiffness in the linkage assembly of a flexible arm |
| 02/24/2005 | WO2005016318A1 Modified-release tablet of bupropion hydrochloride |
| 02/24/2005 | WO2005016288A2 Methods and compositions for treatment of viral diseases |
| 02/24/2005 | WO2005016287A2 Prkwnks as modifiers of the rac pathway and methods of use |
| 02/24/2005 | WO2005016286A2 Pyrazine modulators of cannabinoid receptors |
| 02/24/2005 | WO2005016285A2 Compositions and methods for inhibiting slit protein and glypican interactions |
| 02/24/2005 | WO2005016284A2 Gloves containing dry powdered aloe and method of manufacturing |
| 02/24/2005 | WO2005016283A2 Peptides for enhanced cell attachment and growth |
| 02/24/2005 | WO2005016281A2 Diagnosis and treatment of malignant neoplasms |
| 02/24/2005 | WO2005016280A2 Orally administered small peptides synergize statin activity |
| 02/24/2005 | WO2005016279A2 Melks as modifiers of the rac pathway and methods of use |
| 02/24/2005 | WO2005016277A2 Arylsulfonamidobenzylic compounds |
| 02/24/2005 | WO2005016276A2 Sigma-1 receptor ligand with acetylcholinesterase inhibition properties |
| 02/24/2005 | WO2005016275A2 Formulations containing an immune response modifier |
| 02/24/2005 | WO2005016274A2 Rnai treatment of eye disease |
| 02/24/2005 | WO2005016273A2 Infection prophylaxis using immune response modifier compounds |
| 02/24/2005 | WO2005016272A2 Aryl, heteroaromatic and bicyclic aryl nitrone compounds, prodrugs and pharmaceutical compositions of the same to treat human disorders |
| 02/24/2005 | WO2005016268A2 Alimentary compositions and methods for metabolic modulation |
| 02/24/2005 | WO2005016266A2 Methods for treating cardiovascular disease using a soluble ctla4 molecule |
| 02/24/2005 | WO2005016264A2 Diamine derivatives of quinone and uses thereof |
| 02/24/2005 | WO2005016263A2 Compositions and methods for treating hyperimmune response in the eye |